Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey

Richard G. Wunderink; Michael S. Niederman; Marin H. Kollef; Andrew F. Shorr; Jean Chastre

doi:10.1093/cid/cis334

Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey

Richard G. Wunderink, Michael S. Niederman, Marin H. Kollef, Andrew F. Shorr, Jean Chastre

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	163-165
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	55
Issue number	1
DOIs	https://doi.org/10.1093/cid/cis334
State	Published - Jul 2012

Access to Document

10.1093/cid/cis334

Cite this

@article{1451b688a8b34afab6bcb26c055ec82e,

title = "Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey",

author = "Wunderink, {Richard G.} and Niederman, {Michael S.} and Kollef, {Marin H.} and Shorr, {Andrew F.} and Jean Chastre",

note = "Funding Information: received consulting fees from Pfizer. J. C. has received consulting fees, grant support, and travel support from Pfizer. M. S. N. has received consulting fees and travel support from Pfizer. All other authors report no potential conflicts.",

year = "2012",

month = jul,

doi = "10.1093/cid/cis334",

language = "English",

volume = "55",

pages = "163--165",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

number = "1",

}

TY - JOUR

T1 - Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey

AU - Wunderink, Richard G.

AU - Niederman, Michael S.

AU - Kollef, Marin H.

AU - Shorr, Andrew F.

AU - Chastre, Jean

N1 - Funding Information: received consulting fees from Pfizer. J. C. has received consulting fees, grant support, and travel support from Pfizer. M. S. N. has received consulting fees and travel support from Pfizer. All other authors report no potential conflicts.

PY - 2012/7

Y1 - 2012/7

UR - http://www.scopus.com/inward/record.url?scp=84862227580&partnerID=8YFLogxK

U2 - 10.1093/cid/cis334

DO - 10.1093/cid/cis334

M3 - Letter

AN - SCOPUS:84862227580

SN - 1058-4838

VL - 55

SP - 163

EP - 165

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 1

ER -

Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey

Access to Document

Other files and links

Cite this